Dasatinib targets c-Src kinase in cardiotoxicity
Approved
Classifications
MinEdu publication type
A1 Journal article (peer-reviewed)
Definition
Article
Target group
Scientific
Peer reviewed
Peer-reviewed
Article type
Journal article
Host publication type
Journal
Publication channel information
Title of journal/series
Toxicology reports
ISSN (electronic)
2214-7500
ISSN (linking)
2214-7500
Publisher
Elsevier
Publication forum ID
82227
Publication forum level
1
Country of publication
Netherlands
Internationality
Yes
Detailed publication information
Publication year
2023
Reporting year
2023
Journal/series volume number
10
Page numbers
521-528
DOI
10.1016/j.toxrep.2023.04.013
Language of publication
English
Co-publication information
International co-publication
No
Co-publication with a company
No
Availability
Link to online publication
Link to self-archived version
Classification and additional information
MinEdu field of science classification
3121 General medicine, internal medicine and other clinical medicine
Keywords
Cardiotoxicity; Cell death; Proto-oncogene tyrosine-protein kinase Src; Tyrosine kinase inhibitor
Funding information
Funding information in the publication
This work was supported by research funding from the Academy of Finland grants 297094 and 333284 (R.K.), Sigrid Juselius Foundation (R.K.) and the Finnish Foundation for Cardiovascular Research (M.E., S.R., T.A., J.M., R.K.).
Research data information
Research data information in the publication
Data will be made available on request
Source database ID
Scopus ID
2-s2.0-85153533684